AMRZ three-lens brief
Evidence-based stock research on AMRZ. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Outperforming SPY by 11.7pp over 30 days.
- Outperforming SPY by 11.7pp over 30 days.
AMRZ closed at $41.63 (-0.76%) as of 2026-11-12. Market cap: $22.16B. P/E (trailing) 18.7. Price is above the 50-day MA and below the 200-day MA. Positives: outperforming SPY by 11.7pp over 30 days.. Last quarter: Revenue $3.77B, net income $559.00M, free cash flow $933.25M.
Why three lenses on AMRZ, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AMRZ across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/AMRZ" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AMRZ brief"></iframe>